Polycystic ovary syndrome (PCOS), the major endocrinopathy among reproductive-aged women, is not yet perceived as an important health problem in the world. It affects 4%-20% of women of reproductive age worldwide. The prevalence, diagnosis, etiology, management, clinical practices, psychological issues, and prevention are some of the most confusing aspects associated with PCOS.
Aim
The exact prevalence figures regarding PCOS are limited and unclear. The aim of this review is to summarize comprehensively the current knowledge on the prevalence of PCOS.
Materials and Methods
Literature search was performed through PubMed, ScienceDirect, Cochrane Library, and Google Scholar (up to December 2019). All relevant articles published in English language were identified following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results
Our analysis yielded 27 surveys with a pooled mean prevalence of 21.27% using different diagnostic criteria. The proportion of women with PCOS also increased in the last decade.
Conclusion
The current review summarizes and interprets the results of all published prevalence studies and highlights the burden of the syndrome, thereby supporting early identification and prevention of PCOS in order to reverse the persistent upward trend of prevalence.
PMID 33627974 33627974 DOI 10.4103/jhrs.JHRS_95_18 10.4103/jhrs.JHRS_95_18
Cite this article
Deswal, R., Narwal, V., Dang, A., & Pundir, C. (2020). The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. *Journal of human reproductive sciences*, *13*(4), 261-271. https://doi.org/10.4103/jhrs.JHRS_95_18
Deswal R, Narwal V, Dang A, Pundir C. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020;13(4):261-271. doi:10.4103/jhrs.JHRS_95_18
Deswal, Ritu, et al. "The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review." *Journal of human reproductive sciences*, vol. 13, no. 4, 2020, pp. 261-271.
Yang R et al., 2022
Open Access
The Lancet Regional Health. Western Pacific
Background: Polycystic ovary syndrome (PCOS) has become a major international public health concern. However, because of controversy about the diagnostic criteria and patient selection, estimates of i...
STUDY QUESTION: Is there a difference in live birth rates at 24 months between infertile women with polycystic ovary syndrome (PCOS) who have normal versus abnormal glucose metabolism?
SUMMARY ANSWER...
Brand KM et al., 2025Women's health (London, England)
Influential guidelines have supported the role of metformin in the management of polycystic ovary syndrome (PCOS) for a number of years. However, regulatory approvals for this therapeutic indication a...
Ahsan M et al., 2025The Indian journal of medical research
Background & objectives Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterised by menstrual irregularities, hirsutism, acne, obesity, infertility, and other features adversely affec...